SIG
BIIB icon

Schooner Investment Group’s Biogen BIIB Stock Holding History

Schooner Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,000
Closed -$575K – 158
2015
Q3 		$575K Sell
2,000
-500
-20% -$165K 0.41% 60
2015
Q2 		$1.01M Sell
2,500
-1,000
-29% -$401K 0.48% 51
2015
Q1 		$1.45M Sell
3,500
-1,500
-30% -$591K 0.52% 49
2014
Q4 		$1.71M Buy
+5,000
New +$1.62M 0.45% 84

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Schooner Investment Group's BIIB Position: Q4 2015 in Review

Schooner Investment Group sold out of Biogen (BIIB) in Q4 2015, closing a stake of 2,000 shares — an estimated $575K sold.

Schooner Investment Group first reported a position in BIIB in Q4 2014 and held it in 4 quarters. The position peaked at $1.71M in Q4 2014. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Schooner Investment Group reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Schooner Investment Group sold 2,000 Biogen shares in Q4 2015, an estimated $575K.
  • Schooner Investment Group first reported a position in Biogen in Q4 2014 and held it in 4 quarters.
  • Schooner Investment Group's Biogen position peaked at $1.71M in Q4 2014.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Schooner Investment Group's 13F filing for Q4 2015, filed 11 Feb 2016.